You are Here : Moneycontrol Markets IPO Gland Pharma

IPO Issues Open Now

Gland Pharma

Sector Healthcare

Description Established in Hyderabad, India in 1978, Gland Pharma has grown over the years from a contract manufacturer of small volume liquid parenteral products, to become one of the largest and fastest growing injectable-focused companies, with a global footprint across 60 countries, including the United Sta.... More »

Address 6-3-865/1/2 F No 201, Greenland Apartments Ameerpet , Hyderabad, Telangana , India. Pincode : 50001

Vote Your Expectation of subscription

  • < 0.5X Under Subscribed
  • 0.5-2X Moderately Subscribed
  • >2XOver Subscribed

Vote

  • ‹ 2X Under Subscribed
  • 2-3X Moderately Subscribed
  • 2-10X Over Subscribed
  • ‹ 12x Heavily Subscribed

Vote

Retail Subscritption Poll Results

Total Subscritption Poll Results

Number of Times Issue is Subscribed (BSE + NSE)

As on Date QIB NII RII EMP Total
11-Nov-2020 00:00 6.40 0.51 0.24 2.06
09-Nov-2020 00:00 0.00 0.01 0.08 0.04

Issue Terms

Issue price / Floor Price (Rs) 1490 - 1500
Application per share (Rs) 1,500.00
Minimum investment amount (Rs) 15,000.00
Minimum bid (no of shares) 10
Maximum Shares for Retail N.A.

Issue Date and Size

Issue opens 09-Nov-20
Issue closes 11-Nov-20
Listing on BSE - NSE
Issue size (Rs cr) 6479.55
Mkt cap at issue price (Rs cr) N.A.

Lead Managers & Registrar

Lead Manager E-mail
Kotak Mahindra Capital Company Limited glandpharma.ipo@kotak.com
Citigroup Global Markets India Private Limited glandpharma.ipo@citi.com
Registrar Link Intime India Private Limited
E-mail glandpharma.ipo@linkintime.co.in

Shares on Offer

Shares on Offer Lakhs
Total shares offered N.A.
Of above, offered to public N.A.
Post-issue shares N.A.
Post-issue promoters' holding(%) N.A.

Company Financials (Rs cr)

Financials Crore
No of months N.A.
Turnover N.A.
Net profit / (loss) N.A.
Borrowings N.A.

Forum | Add a comment...

See More

Sections
Thank you for Voting

Why do you think so

Post